IO Biotech
Ayako Wakatsuki Pedersen is an experienced cancer immunologist (15+ years) with preclinical development of immunotherapeutic drugs in biotechs (8+ years).
IO Biotech
2 followers
IO Biotech is a clinical stage biotech company developing disruptive immune therapies for immunological treatment of cancer. Their pipeline of first-in-class immune modulating anti-cancer therapies is based on a unique platform technology enabling the activation of T cells that are specific for immune inhibitory molecules.